Product
Mexidol
Aliases
Ethylmethylhydroxypyridine Succinate
3 clinical trials
3 indications
Indication
strokeIndication
AcuteIndication
Primary Open-Angle Glaucoma (POAG)Clinical trial
Prospective Randomized Study of the Modulating Effect of MEXIDOL® as an Adjuvant Stimulant of the Cognitive-emotional Component of the Rehabilitation Treatment of Patients With Acute Cerebral FailureStatus: Completed, Estimated PCD: 2023-09-12
Clinical trial
Prospective International Multicenter Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety Evaluation of the Mexidol® Sequential Therapy of Patients in the Acute and Early Recovery Periods of Ischemic StrokeStatus: Completed, Estimated PCD: 2023-08-18
Clinical trial
Prospective, Open, Comparative, Randomized Study of the Efficacy and Safety Evaluation of the Mexidol® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG)Status: Completed, Estimated PCD: 2023-11-29